Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MYCYC: Mycophenolate Mofetil vs Cyclophosphamide in ANCA Associated Vasculitis
NCT00414128Phase 3Completed
- Sponsor
- Cambridge University Hospitals NHS Foundation Trust
- Start
- Mar 2007
- Primary completion
- Jul 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of mycophenolate mofetil in Antineutrophil cytoplasmic antibody-associated vasculitis (AAV), sponsored by Cambridge University Hospitals NHS Foundation Trust. Started Mar 2007; status: completed.
02
Drugs
mycophenolate mofetil
03
Conditions
Antineutrophil cytoplasmic antibody-associated vasculitis (AAV)
Beyond the preview
Go deeper on NCT00414128.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00414128.